Clinicopathological characteristics and survival of ALK, ROS1 and RET rearrangements in non-adenocarcinoma non-small cell lung cancer patients
Author:
Affiliation:
1. Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China
2. Key Laboratory Diagnosis & Treatment Technology of Thoracic Oncology, Zhejiang province, Hangzhou, China
Publisher
Informa UK Limited
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/15384047.2016.1235660
Reference25 articles.
1. Cancer statistics in China, 2015
2. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
3. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
4. Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
5. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation;Journal of Experimental Medicine;2024-01-29
2. Genetic Alterations in Lung Cancer;TURK ONCOL DERG;2024
3. Clinical characteristics and progression of pre-/minimally invasive lung adenocarcinoma harboring ALK or RET rearrangements: a retrospective cohort study;Translational Lung Cancer Research;2023-12
4. Clinical Features, Molecular Features and Prognosis of Lung Adeno-Squamous Cell Car-cinoma;Advances in Clinical Medicine;2023
5. Clinicopathological characteristics and prognosis of resectable lung adenosquamous carcinoma: a population-based study of the SEER database;Japanese Journal of Clinical Oncology;2022-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3